According to the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, along with AstraZeneca and R-Pharm, the two vaccines combined have shown promising immunogenicity results.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.